Molly K. Finneseth, MS

Assistant Professor, Obstetrics & Gynecology

850 Harrison Ave


Molly Finneseth, MSN is an Assistant Professor of Obstetrics & Gynecology at the Boston University School of Medicine. She has completed three medical rotations, all in women’s health, with organizations like Planned Parenthood, Brockton Family Planning, and Four Women. Currently, she is a part of the Fellowship in Family Planning Committee and the Ethics Committee at Boston University. Ms. Finneseth was honored by Sigma Theta Tau, the International Society of Nursing and received a nurse traineeship grant award from the US Department of Health & Human Services.

Other Positions

  • Clinical Staff Privileges, Obstetrics & Gynecology, Boston Medical Center


  • MGH Institute of Health Professions, MS
  • Purdue University, BS


  • Published on 11/21/2019

    Paris AE, Vragovic O, Sonalkar S, Finneseth M, Borgatta L. Mifepristone and misoprostol compared to osmotic dilators for cervical preparation prior to surgical abortion at 15-18 weeks' gestation: a randomised controlled non-inferiority trial. BMJ Sex Reprod Health. 2019 Nov 21. PMID: 31754065.

    Read at: PubMed
  • Published on 7/1/2017

    Forman RN, Mehta PK, Louis KR, Finneseth MK, Yarrington CD. Addressing the Global Zika Epidemic Locally: An Interprofessional Model of Universal Screening at One Center. J Perinat Neonatal Nurs. 2017 Jul/Sep; 31(3):216-224. PMID: 28590945.

    Read at: PubMed
  • Published on 10/25/2012

    Roncari D, Politch JA, Sonalkar S, Finneseth M, Borgatta L. Inflammation or infection at the time of second trimester induced abortion. Contraception. 2013 Jan; 87(1):67-70. PMID: 23102591.

    Read at: PubMed
  • Published on 6/6/2012

    Borgatta L, Roncari D, Sonalkar S, Mark A, Hou MY, Finneseth M, Vragovic O. Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial. Contraception. 2012 Nov; 86(5):567-71. PMID: 22682721.

    Read at: PubMed

View all profiles